Literature DB >> 6807684

Kinetics of primary bile acids in patients with non-operated Crohn's disease.

P Rutgeerts, Y Ghoos, G Vantrappen.   

Abstract

The metabolism of cholic acid and chenodeoxycholic acid was studied in seventeen patients with non-operated Crohn's disease, eleven ileitis and six ileocolitis patients. The turnover of cholic acid was significantly increased in patients with ileitis (k = 2.01 +/- 1.13 days-1; P less than 0.001) and ileocolitis (k = 0.91 +/- 0.47 days-1; P less than 0.005) as compared to normals (k = 0.35 +/- 0.19 days-1). Although chenodeoxycholic acid was better preserved in the enterohepatic circulation than cholic acid its turnover was also significantly faster in ileitis (k = 0.81 +/- 0.56 days-1; P less than 0.005) and ileocolitis patients (k = 0.62 +/- 0.18 days-1; P less than 0.01) than in normals (k = 0.20 +/- 0.09 days-1). The fractional turnover of cholic acid was related to the length of ileal involvement (r = 0.761; P less than 0.001; n = 17). Patients with Crohn's ileitis tended to preserve normal fasting total bile acid pools by increased synthesis of primary bile acids and efficient absorption of deoxycholic acid and ursodeoxycholic acid by the normal colon. Patients with active ileocolitis had decreased total fasting pool sizes (2.62 +/- 1.83 mmol; P less than 0.001) as compared to normals (7.69 +/- 1.61 mmol). In these patients there was no increase in bile acid synthesis as compared to normals and secondary bile acids were absent from bile. It is concluded that the colon has an important role in maintaining the fasting pool size to a normal level in the presence of an interrupted enterohepatic circulation of bile acids due to ileal disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6807684     DOI: 10.1111/j.1365-2362.1982.tb00950.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  Do steroids ameliorate bile acid malabsorption in Crohn's disease?

Authors:  R S Kwon; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 2.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.

Authors:  Aonghus Lavelle; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-19       Impact factor: 46.802

3.  Intestinal absorption of bile acids in the pig. Role of distal bowel.

Authors:  C Juste; V Legrand-Defretin; T Corring; A Rerat
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

4.  Biliary lipid composition in patients with nonoperated Crohn's disease.

Authors:  P Rutgeerts; Y Ghoos; G Vantrappen; J Fevery
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

5.  Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo.

Authors:  E F Stange; J Scheibner; H Ditschuneit
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.

Authors:  Abhik Roy; Simon Lichtiger
Journal:  Inflamm Bowel Dis       Date:  2016-03       Impact factor: 5.325

7.  Glucocorticoids differentially regulate Na-bile acid cotransport in normal and chronically inflamed rabbit ileal villus cells.

Authors:  Steven Coon; Ramesh Kekuda; Prosenjit Saha; Uma Sundaram
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-14       Impact factor: 4.052

8.  Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.

Authors:  Carsten Gnewuch; Gerhard Liebisch; Thomas Langmann; Benjamin Dieplinger; Thomas Mueller; Meinhard Haltmayer; Hans Dieplinger; Alexandra Zahn; Wolfgang Stremmel; Gerhard Rogler; Gerd Schmitz
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

9.  Effects of dietary butter fat on fecal bile acid excretion in patients with Crohn's disease on elemental diet.

Authors:  T Koga; T Nishida; H Miwa; M Yamamoto; K Kaku; T Yao; M Okumura
Journal:  Dig Dis Sci       Date:  1984-11       Impact factor: 3.199

10.  Tests for the absorption of 75Se-labelled homocholic acid conjugated with taurine (75Se-HCAT).

Authors:  H J Schroth; R Berberich; G Feifel; K P Müller; K W Ecker
Journal:  Eur J Nucl Med       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.